Organisation paid for research Program year 2025 Source: CMS Open Payments

Texas Diabetes & Endocrinology PA

Neither a doctor nor a teaching hospital

Research payments

$7,154,281

756 payments

Through program year 2025, Texas Diabetes & Endocrinology PA is reported as receiving $7,154,281 in research payments, across 756 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$1,748,978	116
2024	Research	$753,622	72
2023	Research	$1,059,869	97
2022	Research	$477,994	99
2021	Research	$724,177	139
2020	Research	$1,784,137	177
2019	Research	$605,504	56

Breakdown

Who paid Research payments · program years 2019–2025

Dexcom, Inc. $1,940,892 69 payments
Medtronic MiniMed, Inc. $1,692,857 143 payments
AbbVie, Inc. $1,229,088 96 payments
Medtronic, Inc. $1,139,527 251 payments
Allergan Inc. $841,243 133 payments
Mannkind Corporation $135,479 10 payments
Hoffmann-La Roche Limited $93,305 18 payments
Genentech, Inc. $61,890 11 payments
Takeda Pharmaceuticals U.S.A., Inc. $15,900 21 payments
Shire North American Group Inc $2,100 3 payments

Studies the money was for Research payments · program years 2019–2025

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants $932,656 60 payments
A multicenter, randomized, double-blind, dose-conversion study to evaluate the safety and efficacy of HRT w Armour Thyroid compared to levothyroxine (T4) in previously hypothyroid participants, who are on euthyroid T4 replacement $588,603 51 payments
CIP330 Synergy $471,965 24 payments
Evaluation of Modified Adhesives With Dexcom G7 Sensors (Beta Oh8) $453,450 10 payments
CEP 304 670G Outcomes Study $447,237 30 payments
Cip332 NGS $435,820 39 payments
CIP318 Unity Feasibility $326,312 34 payments
CIP324 Zeus Pivotal $324,355 29 payments
CIP331 Smart Pen $320,598 92 payments
Evaluation of the Dexcom Continuous Glucose Monitoring (CGM) System Survivability and Data Delivery Reliability in Adults and Pediatrics With Type 1 and Type 2 Diabetes $301,020 14 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.